Postnatal steroids and neurodevelopmental outcomes: a problem in the making.
Barrington
K J
KJ
Division of Neonatology, Room C7.68 Royal Victoria Hospital, 687 Pine Ave West, Montreal, Quebec H3A 1A1 Canada. keith.barrington@mcgill.ca
D000305:Adrenal Cortex Hormones / Q000009:adverse effects* / Q000627:therapeutic use; D001997:Bronchopulmonary Dysplasia / Q000188:drug therapy / Q000517:prevention & control*; D002547:Cerebral Palsy / Q000139:chemically induced / Q000453:epidemiology; D002657:Child Development / Q000187:drug effects*; D002908:Chronic Disease; D003907:Dexamethasone / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D006854:Hydrocortisone / Q000009:adverse effects / Q000627:therapeutic use; D007231:Infant, Newborn; D019102:Infant, Very Low Birth Weight; D008171:Lung Diseases / Q000453:epidemiology / Q000517:prevention & control; D009422:Nervous System Diseases / Q000139:chemically induced*; D016032:Randomized Controlled Trials as Topic / Q000706:statistics & numerical data; D012306:Risk; D016896:Treatment Outcome; D014481:United States / Q000453:epidemiology
D000305:Adrenal Cortex Hormones; D003907:Dexamethasone; D006854:Hydrocortisone